Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Dr Liz Evans for UK Column: The Awful Ozempic Truth
UKMFA
13 minutes
6 months ago
Dr Liz Evans for UK Column: The Awful Ozempic Truth
https://rumble.com/v6056un-ukmfa-disclaimer.html Reporting for UK Column, our CEO, Dr Liz Evans, presents her jaw dropping findings about weight loss drugs, the big Pharma sponsorship behind the regulation and the awful, possible side-effects!! Find the original video here: https://rumble.com/v6v0hdj-miracle-weight-loss-injections-big-pharmas-newest-subscription-scheme-uk-co.html UKMFA: CALL TO ACTION: Please follow us and subscribe on our YouTube and Rumble channels and please share our c...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
